// App-Quantinova.ai

POS0509 (2022) : DEVELOPMENT OF A MULITNOMIAL PREDICTION MODEL OF TREATMENT RESPONSE TO ETANERCEPT IN A MULTI-CENTRE COHORT OF PATIENTS WITH ESTABLISHED RA

Researchers

Presenter

  • M. Stadler

Principal Investigators

  • S. Ling

  • N. Nair

  • J. Isaacs

  • K. Hyrich

  • A. Morgan

  • A. G. Wilson

  • D. Plant

  • J. Bowes

  • A. Barton

Medical Centers

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

  • Newcastle University, Translational and Clinical Research Institute, Newcastle University and Musculoskeletal Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom

  • Manchester CRF South, Manchester University NHS Foundation Trust, Manchester, United Kingdom,

  • Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University Of Manchester, Manchester, United Kingdom

  • Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, Dublin, Ireland

Locations

  • United Kingdom

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved